OPRX OptimizeRx Corp
Price Chart
Executive Summary
OptimizeRx disclosed the separation of Chief Commercial Officer Theresa Greco, effective June 15, 2026, with a separation agreement providing 12 months of base salary continuation ($380,000), a $209,000 lump-sum bonus, and COBRA reimbursement. Greco will serve as an advisor for 12 months with continued equity vesting. The departure was previously disclosed in the Q1 2026 10-Q and appears planned, not unexpected.
Actionable Insight
This is a routine CCO departure with a planned transition and advisory retention — no red flags. The cross-filing DEFA14A (4 days prior) relates to an equity plan amendment vote, not this departure. Monitor the next 10-Q for any further executive changes or operational disruption commentary.
Key Facts
- Chief Commercial Officer Theresa Greco to depart effective June 15, 2026
- Separation agreement includes 12 months base salary continuation ($380,000/year), $209,000 lump-sum bonus, and COBRA reimbursement
- Greco will provide advisory services for 12 months through June 15, 2027, with continued equity vesting
- Non-compete and non-solicitation restrictions apply for 12 months
- Departure was previously disclosed in the Q1 2026 10-Q, indicating a planned transition
Financial Impact
Total cash consideration to Greco of approximately $589,000 ($380,000 salary + $209,000 bonus) plus COBRA costs — immaterial relative to company market cap of $101M
Risk Factors
- Loss of commercial leadership could slow sales execution during transition
- Advisory role may not fully replace active CCO responsibilities
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-065810 |
| Document: 0001213900-26-065810-index-headers.html | 0001213900-26-065810 |
| Document: 0001213900-26-065810-index.html | 0001213900-26-065810 |
| Document: 0001213900-26-065810.txt | 0001213900-26-065810 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
today
|
8-K
| $5.24 awaiting T+5 | awaiting T+5 | — | $5.23 (−0.19%) |
|
Jun 11, 2026
1d ago
|
Institutional Cluster
| $5.13 awaiting T+5 | awaiting T+5 | — | $5.23 (+2.05%) |
|
Jun 5, 2026
7d ago
|
8-K
| $5.12 awaiting T+5 | awaiting T+5 | — | $5.23 (+2.15%) |
|
Jun 1, 2026
11d ago
|
DEFA14A
| $5.38 $5.11 | ▼ −5.02% | ▼ −2.27% | $5.23 (−2.79%) |
|
May 21, 2026
22d ago
|
Press Release
| $4.94 $5.19 | ▲ +5.06% | ▲ +3.21% | $5.23 (+5.87%) |
|
May 12, 2026
4w ago
|
Press Release
| $4.92 $4.83 | ▼ −1.83% | ▼ −0.67% | $5.23 (+6.30%) |
|
Mar 5, 2026
14w ago
|
Press Release
| $6.74 $6.40 | ▼ −5.04% | ▼ −3.52% | $5.23 (−22.40%) |
|
Mar 5, 2026
14w ago
|
8-K
| $6.74 $6.40 | ▼ −5.04% | ▼ −3.52% | $5.23 (−22.40%) |
|
Mar 5, 2026
14w ago
|
Press Release
| $6.74 $6.40 | ▼ −5.04% | ▼ −3.52% | $5.23 (−22.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access